As expected, IFITM3 was found to be highly correlated with most immune checkpoints in BLCA, including CD274, PDCD1, and CTLA4 (Figure 2G, Supplementary Figure S4G). Here, IFITM3 is linked to bladder transitional cell carcinoma.